Cite

HARVARD Citation

    Ward, M. et al. (2017). Intra‐patient variability in adalimumab drug levels within and between cycles in Crohn's disease. Alimentary pharmacology & therapeutics. 45 (8), pp. 1135-1145. [Online]. 
  
Back to record